Boone Capital Management LLC Buys 10,138 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Boone Capital Management LLC increased its stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 14.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 81,842 shares of the company's stock after purchasing an additional 10,138 shares during the quarter. Molina Healthcare makes up approximately 8.0% of Boone Capital Management LLC's holdings, making the stock its 5th largest holding. Boone Capital Management LLC owned 0.14% of Molina Healthcare worth $23,820,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its holdings in Molina Healthcare by 83.1% in the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company's stock valued at $47,000 after buying an additional 74 shares during the period. Wingate Wealth Advisors Inc. acquired a new stake in shares of Molina Healthcare during the 4th quarter worth $52,000. Hurley Capital LLC acquired a new position in Molina Healthcare in the fourth quarter valued at $55,000. EverSource Wealth Advisors LLC increased its stake in Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after acquiring an additional 88 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd grew its holdings in shares of Molina Healthcare by 895.0% during the 4th quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock worth $58,000 after purchasing an additional 179 shares during the period. Institutional investors and hedge funds own 98.50% of the company's stock.

Insider Activity

In related news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now directly owns 17,375 shares in the company, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the transaction, the chief executive officer now directly owns 257,715 shares of the company's stock, valued at $82,484,262.90. The trade was a 25.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 89,169 shares of company stock valued at $28,520,995. 1.10% of the stock is currently owned by company insiders.

Molina Healthcare Stock Performance

Shares of NYSE MOH opened at $319.61 on Tuesday. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The firm's 50-day moving average price is $322.95 and its two-hundred day moving average price is $307.51. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $365.23. The stock has a market capitalization of $17.32 billion, a P/E ratio of 15.64, a P/E/G ratio of 1.06 and a beta of 0.70.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.96 by $0.12. The business had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The business's revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the business posted $5.73 EPS. As a group, sell-side analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Baird R W downgraded shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $295.00 to $372.00 in a research report on Wednesday, March 5th. Robert W. Baird reaffirmed a "neutral" rating and set a $375.00 price target (up from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Stephens reaffirmed an "equal weight" rating and set a $345.00 target price on shares of Molina Healthcare in a research report on Thursday, February 6th. Finally, Barclays raised their price target on shares of Molina Healthcare from $339.00 to $362.00 and gave the stock an "equal weight" rating in a research report on Friday, April 25th. Nine equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Molina Healthcare presently has a consensus rating of "Hold" and an average target price of $365.38.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.